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Abstract
Fast-spiking interneurons (FSIs) control the output of the striatum by mediating feed-forward GABAergic inhibition of projection
neurons. Their neuromodulation can therefore critically affect the operation of the basal ganglia. We studied the effects of 5-
hydroxytryptamine (5-HT, serotonin), a neurotransmitter released in the striatum by fibres originating in the raphe nuclei, on FSIs
recorded with whole-cell techniques in rat brain slices. Bath application of serotonin (30 lm) elicited slow, reversible depolarizations
(9 ± 3 mV) in 37 ⁄ 46 FSIs. Similar effects were observed using conventional whole-cell and gramicidin perforated-patch techniques.
The serotonin effects persisted in the presence of tetrodotoxin and were mediated by 5-HT2C receptors, as they were reversed by the
5-HT2 receptor antagonist ketanserin and by the selective 5-HT2C receptor antagonist RS 102221. Serotonin-induced depolarizations
were not accompanied by a significant change in FSI input resistance. Serotonin caused the appearance of spontaneous firing in a
minority (5 ⁄ 35) of responsive FSIs, whereas it strongly increased FSI excitability in each of the remaining responsive FSIs,
significantly decreasing the latency of the first spike evoked by a current step and increasing spike frequency. Voltage-clamp
experiments revealed that serotonin suppressed a current that reversed around )100 mV and displayed a marked inward
rectification, a finding that explains the lack of effects of serotonin on input resistance. Consistently, the effects of serotonin were
completely occluded by low concentrations of extracellular barium, which selectively blocks Kir2 channels. We concluded that
the excitatory effects of serotonin on FSIs were mediated by 5-HT2C receptors and involved suppression of an inwardly rectifying
K+ current.
Introduction
The striatum is the main input area of the basal ganglia and it plays
a crucial role in motor control and reward-mediated learning
(Bolam et al., 2000; Bevan et al., 2002; Graybiel, 2005; McHafﬁe
et al., 2005; Redgrave & Gurney, 2006). Striatal projection neurons,
which receive strong glutamatergic inputs from the cortex and
thalamus (Cherubini et al., 1988; Mallet et al., 2006), constitute
> 95% of the striatal neuronal population (Graveland & DiFiglia,
1985). Despite their relative scarcity, however, GABAergic and
cholinergic interneurons can control large striatal areas through their
axonal arborizations and have emerged as a major target for
neuromodulation (Kita et al., 1990; Kubota & Kawaguchi, 2000;
Tepper & Bolam, 2004). Among the GABAergic interneurons, fast-
spiking interneurons (FSIs) are the most numerous class (Tepper &
Bolam, 2004) and their ability to powerfully inhibit projection
neurons has been demonstrated both in vitro (Koos & Tepper, 1999;
Koos et al., 2004) and in vivo (Mallet et al., 2005, 2006). This
inhibition is referred to as feed-forward because the FSIs receive a
strong excitatory input from the cortex, which is also the major
source of excitation for the projection neurons (Ramanathan et al.,
2002). The rarity of the FSIs and the fact that, unlike large
cholinergic interneurons, they cannot be visually identiﬁed in brain
slices, make systematic electrophysiological studies on these cells
challenging. Nevertheless, we and other groups have shown that
FSIs are excited by dopamine and acetylcholine (Bracci et al.,
2002; Koos & Tepper, 2002; Centonze et al., 2003). Another
neurotransmitter that is crucially involved in cognitive and motor
functions is serotonin (Sandyk & Fisher, 1988; Meneses, 1999;
Geyer & Vollenweider, 2008). This amine, whose function is
characterized by a complex interaction with the dopaminergic
system (Di Giovanni et al., 2008), is released in the striatum by
dense terminal projections mainly arising from the dorsal raphe
nucleus (Lavoie & Parent, 1990; Vertes, 1991). Consistently,
serotonin and its receptors are extremely abundant in the striatum
(for a recent review see Di Matteo et al., 2008). In-vivo
experiments have shown that activation of serotonin receptors in
the striatum elicits predominantly inhibitory responses in projection
neurons (el Mansari et al., 1994; el Mansari & Blier, 1997). The
cellular mechanisms underlying these effects are not completely
understood. We have previously shown that serotonin excites
striatal cholinergic interneurons (Blomeley & Bracci, 2005) and that
these cells, in turn, inhibit the glutamatergic input to projection
neurons (Pakhotin & Bracci, 2007). In order to gain a more
complete picture of the action of serotonin in the striatum, we have
investigated the effects of this neurotransmitter on FSIs, which also
exert a major inhibitory inﬂuence on the striatal output.
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Materials and methods
Wistar rats (both sexes, postnatal day 16–27, supplied by Biological
Services Facility, University of Manchester, UK) were used for the
experiments. Overall, 57 animals were used; the number of animals
used for each experiment corresponds to n indicated in the Results, as
each FSI was recorded from a different animal. The animals were
killed using cervical dislocation, a humane method of killing in
accordance with the UK Animals (Scientiﬁc Procedures) Act 1986 and
the European Communities Council Directive (86 ⁄ 609 ⁄ EEC). Coro-
nal brain slices (300 lm thick) were obtained using a vibroslicer and
maintained at 25C in oxygenated artiﬁcial cerebrospinal ﬂuid
[composition (in mm): 126 NaCl, 2.5 KCl, 1.3 MgCl2, 1.2 NaH2PO4,
2.4 CaCl2, 10 glucose, 18 NaHCO3]. For recordings, slices were
submerged, superfused (2–3 mL ⁄min) at 25C and visualized with
infrared ⁄ differential interference contrast microscopy. Drugs were
bath-applied. Current-clamp recordings were performed in bridge
mode using an Axoclamp-2B ampliﬁer (Axon Instruments) or a
BA-1S bridge ampliﬁer (NPI electronic GmbH). Voltage-clamp
recordings were performed using the AxoClamp-2B in continuous
single-electrode mode, with uncompensated series resistance. Whole-
cell recordings were obtained with patch pipettes (2–5 MX) ﬁlled with
a solution containing (in mm): 125 potassium gluconate, 10 NaCl,
1 CaCl2, 2 MgCl2, 1 BAPTA, 19 HEPES, 0.4 Mg-GTP, 4 Mg-ATP,
and adjusted to pH 7.3 with KOH.
Input resistance was measured in current-clamp experiments
by applying small negative current steps (0.5–1 s long), eliciting
2–10 mV deﬂections in FSIs. If the FSI was depolarized as a result of
a pharmacological treatment, it was manually repolarized to control
level for a short period while the current steps were applied; in this
way, input resistance measurements were obtained at the same
membrane potential. The input resistance was calculated by dividing
the steady-state voltage deﬂection (measured at the end of the step) by
the amplitude of the current step. For each pharmacological condition
tested, 5–25 current steps were applied at 10 s intervals; the input
resistance measurements for each condition were then grouped for
statistical analysis.
For perforated-patch recordings, gramicidin (10–20 lg ⁄mL) was
added to the intrapipette solution and perforation was monitored as
described in Blomeley & Bracci (2005).
The curve of best ﬁt for the average current suppressed by serotonin
was obtained using the equation: I = g(Vm) · (Vm ) Ek), where
g(Vm) was described by a Boltzmann’s equation: g(Vm) = gmax((1 +
exp(Vm ) Ek ) DVh))m
)1))1. The parameters gmax, DVh and m yielding
the curve of best ﬁt were obtained using the method of non-linear least
squares provided by matlab software (The MathWorks). The slope
conductance associated with the serotonin-suppressed current was
estimated using the curve of best ﬁt for I(Vm); the voltage domain was
divided into 1 mV intervals and the slope conductance was calculated
as the ratio DI : DV for each of these intervals.
For action potential half-width measurements, the spike threshold
was deﬁned as the point where the rate of depolarization exceeded
75 mV ⁄ms; spike amplitude was measured as the difference between
the threshold level and the peak of the spike. For each FSI, 10–30
suprathreshold depolarizing current steps were applied every 10 s in
each pharmacological condition, and the half-width of the ﬁrst spike
induced by each step was measured and used for statistical comparison.
Experimental values are expressed as mean ± SD and all statistical
comparisons were carried out using non-directional Mann–Whitney
U-tests (originpro 8 software). Drugs were obtained from Tocris
Bioscience UK, apart from 5-hydroxytryptamine (5-HT) hydrochlo-
ride and gramicidin, which were obtained from Sigma-Aldrich UK.
Results
Electrophysiological identification of striatal fast-spiking
interneurons
The ﬁrst two postnatal weeks are critical for FSI development
(Chesselet et al., 2007). Thus, we used animals of postnatal day
16–27. We recorded from 49 striatal FSIs using conventional whole-
cell techniques and from eight FSIs using gramicidin perforated-patch
techniques (Blomeley & Bracci, 2005). FSIs were identiﬁed based on
their distinctive electrophysiological features, including: (i) intermit-
tent ﬁring at high frequency; (ii) narrow action potentials (half-width
< 1 ms); (iii) large spike afterhyperpolarizations; and (iv) subthreshold
oscillations (amplitude 1–5 mV) observed between spike bursts
(Kawaguchi, 1993; Bracci et al., 2003). Examples of these properties
are shown in Fig. 1A and B. The average resting membrane potential
of the FSIs (in the absence of any injected current) was )69 ± 5 mV
and the average input resistance was 203 ± 34 MX (average input
conductance was 5.7 ± 1.9 nS). Access resistance (regularly compen-
sated in bridge mode) was 3–4 MX and did not change by more than
30% in these experiments.
Effects of serotonin on fast-spiking interneurons and receptors
involved
In order to establish whether serotonin caused direct effects on FSIs,
we carried out a series of experiments in the presence of the sodium
channel blocker tetrodotoxin (TTX) (1 lm). Serotonin (30 lm, a dose
that produces maximal effects in cholinergic interneurons) induced
reversible depolarizing effects (8.4 ± 3.6 mV) in 4 ⁄ 5 FSIs tested in
the presence of TTX using conventional whole-cell recordings
(Fig. 1C). These depolarizations reached maximal value at
11.7 ± 1.5 min after the onset of serotonin application. In 4 ⁄ 4 cases
in which a depolarization was observed, no signiﬁcant changes in the
apparent cell input resistance were observed during serotonin appli-
cation (as shown in the example of Fig. 1C).
In another series of experiments, we applied serotonin in the
absence of TTX to investigate its effects on FSI excitability. Under
these conditions, serotonin induced reversible membrane depolariza-
tions (8.9 ± 2.8 mV) in 27 ⁄ 33 FSIs recorded with conventional
whole-cell techniques (time to maximal depolarization was
10.4 ± 3.0 min). In the 6 ⁄ 33 cells that did not respond to 30 lm
serotonin, subsequent application of higher concentrations (60–
120 lm) failed to elicit signiﬁcant effects. In most cases, serotonin-
induced depolarizations per se did not elicit action potentials.
However, in ﬁve FSIs serotonin did cause the appearance of
spontaneous action potentials (at an average frequency of
3.6 ± 2.1 Hz), as shown in the examples of Figs 2B and 6A. The
input resistance was monitored in 16 FSIs depolarized by serotonin in
control solution. As observed in the presence of TTX, we found that
overall there were no signiﬁcant changes in the apparent input
resistance of these FSIs in the presence of serotonin. On average, the
FSI input resistance measured with small current steps in the presence
of serotonin was 96 ± 5% of that observed in control solution.
In other basal ganglia neurons, serotonin depolarizing effects are
mediated by 5-HT2 receptors (Blomeley & Bracci, 2005; Stanford
et al., 2005; Bonsi et al., 2007). To test the involvement of these
receptors, we applied the 5-HT2 receptor antagonist ketanserin
(10 lm) in nine experiments in which serotonin had depolarized FSIs
by > 5 mV (four of these experiments were carried out in the presence
of TTX). In 9 ⁄ 9 cases, ketanserin (applied in the presence of
serotonin) fully reversed the serotonin effects, causing the membrane
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potential to return either to the level observed in control solution (5 ⁄ 9
cells, two of which were recorded in the presence of TTX) or to more
hyperpolarized levels (on average by 3.1 ± 1.4 mV; 4 ⁄ 9 cells, two of
which were recorded in the presence of TTX). Two cases in which
ketanserin caused the membrane potential to attain levels more
negative than in control solution are presented in Fig. 2A and B.
To further test the hypothesis that the effects of serotonin were
mediated by 5-HT2 receptors, we also investigated the effects
of the 5-HT2 receptor agonist a-methyl-5-HT (30 lm) on FSIs.
a-methyl-5-HT produced depolarizing effects (8.0 ± 1.7 mV) simi-
lar to those of serotonin in 6 ⁄ 7 FSIs, as shown in the example
of Fig. 2C. In 6 ⁄ 6 FSIs depolarized by a-methyl-5-HT, the
Fig. 1. Effects of serotonin on FSIs in the presence of TTX. (A) Electrophysiological properties of an FSI revealed by current injections (± 100 pA). (B) Rhythmic
intermittent ﬁring was observed in another FSI depolarized by a steady current injection. (C) Serotonin (30 lm) reversibly depolarized an FSI in the presence of TTX
(1 lm). Input resistance was monitored using current pulses (15 pA, 1 s) applied every 10 s. During the depolarization induced by serotonin, the FSI was manually
repolarized to control level, to measure input resistance. Expanded traces are averages of 20 voltage deﬂections elicited by consecutive current pulses in each
condition (control, serotonin and washout). No signiﬁcant changes in input resistance were observed.
Fig. 2. Serotonin effects are mediated by 5-HT2 receptors. (A) Serotonin depolarized an FSI in the presence of TTX (1 lm). Subsequent addition of ketanserin
(10 lm) caused the FSI to hyperpolarize to a level more negative than control. During the depolarization induced by serotonin, the FSI was transiently repolarized to
control level to measure input resistance (not signiﬁcantly different from control). (B) In this experiment, an FSI (recorded without steady current injection) did not
display any spontaneous ﬁring activity in control solution. Serotonin induced a depolarization accompanied by spontaneous bursts of action potentials. Subsequent
application of the 5-HT2 receptor antagonist ketanserin (10 lm) repolarized the FSI and abolished spontaneous ﬁring. (C) Another FSI, with a resting membrane
potential of )69 mV, was depolarized (9 mV) by the 5-HT2 receptor agonist a-methyl-5-HT (30 lm). Subsequent addition of ketanserin reversed these effects. All
vertical deﬂections in the slow time-scale trace are depolarizations induced by current steps (50 pA, 1 s), which were delivered to monitor the excitability of the FSI.
Three representative responses to such current steps in different pharmacological conditions are shown below the slow time-scale trace. (D) In this experiment, bath
application of serotonin caused a depolarization (12 mV) from a resting membrane potential of )74 mV in an FSI; in the presence of serotonin, application of the
selective 5-HT2C receptor antagonist RS 102221 caused the membrane to repolarize to levels slightly more negative ()76 mV) than that observed in control solution.
Washout of RS 102221 (still in the presence of serotonin) caused the membrane potential to depolarize again to a level similar to that observed in the presence of
serotonin before RS 102221 application; subsequent reapplication of RS 102221 (still in the presence of serotonin) caused the FSI to repolarize again at )76 mV.
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subsequent addition of ketanserin completely reversed these effects
(not shown).
These data clearly indicated that serotonin depolarized FSIs acting
on 5-HT2 receptors. The 5-HT2A and 5-HT2C receptor subtypes are
abundantly expressed in the striatum (Di Matteo et al., 2008); 5-HT2A
receptors are mainly found in medium spiny projection neurons
(Rodriguez et al., 1999). We therefore investigated whether the effects
of serotonin on FSIs were mediated by 5-HT2C receptors, using the
subtype-speciﬁc antagonist RS 102221 (Stanford et al., 2005). In ﬁve
FSIs in which serotonin had caused a depolarization (9.7 ± 2.2 mV),
subsequent application of RS 102221 (1 lm), still in the presence of
serotonin, fully reversed these effects, causing the membrane potential
to return to levels slightly more negative (on average by
1.1 ± 1.4 mV) than that observed in control solution. In four of these
ﬁve FSIs, RS 102221 was then washed out, still in the presence of
serotonin, and subsequently reapplied (after > 10 min). In all cases,
removal of RS 102221 caused the FSI membrane potential to return to
depolarized levels similar to those observed during the ﬁrst application
of serotonin, whereas reapplication of RS 102221 caused repolariza-
tions to levels slightly more negative than that observed in control
solution. An example of these effects is illustrated in Fig. 2D; in this
experiment, RS 102221 was applied and washed out twice in the
presence of serotonin. The ability of RS 102221 to completely reverse
the effects of serotonin showed that the effects of serotonin on FSIs
were entirely mediated by 5-HT2C receptors.
In control solution, the effects of serotonin or a-methyl-5-HT on FSI
excitability were tested by repeatedly depolarizing these cells with
current injections before and after drug application. An example of
these experiments is illustrated in Fig. 2C. In this case, the current
steps (50 pA, 1 s) elicited 2 ± 1 spikes in control solution, whereas
the same steps elicited 18 ± 3 spikes in the presence of a-methyl-5-HT
(P < 0.001). A Mann–Whitney U test was carried out on the number
of spikes elicited by 10 consecutive steps in control solution and 10 in
the presence of a-methyl-5-HT; in each case the steps were applied
every 10 s; when ketanserin was added, the number of spikes
decreased back to 2 ± 1 (10 steps). Similar results were observed in
6 ⁄ 6 FSIs, in which either serotonin or a-methyl-5-HT had induced,
per se, subthreshold depolarizations; in all cases current steps elicited
signiﬁcantly more spikes in the presence of serotonin or a-methyl-
5-HT than in control solution (P < 0.001; calculated on number of
spikes elicited by at least 10 steps in each experiment for each
pharmacological condition).
In another series of experiments, we used current steps that elicited
at least two spikes in control solution. At least 10 identical steps were
applied (every 10 s), in control solution and in the presence of
serotonin, to seven FSIs, which were recorded without steady current
injections. In control solution, the latency of the ﬁrst spike was
134 ± 35 ms and the ﬁrst inter-spike interval was 245 ± 88 ms. In
each of these seven FSIs, serotonin induced depolarizations of
> 5 mV and signiﬁcantly (P < 0.01; 10–20 measurements per cell per
condition) decreased the latency of the ﬁrst spike (on average by
53 ± 10%) and the ﬁrst inter-spike intervals (P < 0.03; 10–20
measurements per cell per condition) (on average by 63 ± 8%). An
example of the effects of serotonin on spike latency, and their reversal
after serotonin washout, is shown in Fig. 3A. An example of the
effects of serotonin on the ﬁrst inter-spike interval is illustrated in
Fig. 3B. The average changes induced by serotonin on spike latency
and the ﬁrst inter-spike interval for each neuron tested are illustrated in
Fig. 3C. Collectively, these experiments clearly showed that, even
when the depolarizing effects of serotonin or a-methyl-5-HT were
per se subthreshold, they strongly facilitated spike generation induced
by concomitant excitatory stimuli.
In a previous study on cholinergic interneurons, the effects of
serotonin could only be observed using perforated-patch techniques
(Blomeley & Bracci, 2005). The observations reported so far with
conventional whole-cell recordings show that this was not the case for
FSIs; this is consistent with the observation that the physiological
properties of FSI, unlike cholinergic interneurons, do not run down
during long (> 2 h) conventional whole-cell recordings. Nevertheless,
we carried out some perforated-patch recordings to test whether
serotonin elicited additional effects not observed with conventional
recordings. Under these conditions, in control solution, serotonin
depolarized 6 ⁄ 8 FSIs and elicited no effects in 2 ⁄ 8 cells. The maximal
amplitude of these depolarizations (8.1 ± 2.2 mV) and the time to
peak (10.9 ± 2.8 min) were not signiﬁcantly different from those
observed with conventional whole-cell recordings (P = 0.94; n = 6 for
gramicidin-perforated experiments and n = 27 for conventional
whole-cell recordings). We concluded that the use of perforated patch
was not critical to study serotonin effects on FSIs.
Conductances modulated by serotonin
The observation that the effects of serotonin persisted in the presence of
TTX suggests that its action did not involve the voltage-activated
sodium currents responsible for spike generation. Consistent with this
notion, serotonin did not signiﬁcantly (P > 0.07; at least 10 spikes per
condition) affect action potential half-width in any of the 22 FSIs
tested, as shown in the example of Fig. 3D. Although the action
potential depolarizing phase is largely determined by sodium currents,
Kv3.1–Kv3.2 potassium channels are mainly responsible for the
repolarizing phase in FSIs (Erisir et al., 1999). The absence of
signiﬁcant effects on action potential half-width also suggests that
serotonin did not affect these conductances. We then investigated the
action of serotonin on the currents active in the subthreshold membrane
potential range. In order to do this, we carried out voltage-clamp
experiments in seven FSIs in the presence of TTX. At Vh = )80 mV,
serotonin induced an inward current in each of these seven FSIs (on
average, )41.0 ± 5.7 pA). The time-course of serotonin responses was
similar to that observed in current-clamp recordings. In four FSIs, a
series of voltage steps (1 s long) were applied in control solution and in
the presence of serotonin (after > 30 min from the onset of the
application). These steps were delivered from a holding potential
of )80 mV to levels between )110 and )40 mV, in 10 mV increments.
A representative example of these experiments is shown in Fig. 4A.
The steady-state current values for this FSI are plotted against
membrane potential in Fig. 4B. The difference between steady-state
currents in control solution and in the presence of serotonin is plotted as
a function of voltage in Fig. 4C. This difference current, which
represents the current suppressed by serotonin, reversed polarity at
)98 mVand displayed a prominent inward rectiﬁcation. Similar results
were observed in the other FSIs. On average, the reversal potential of
serotonin-induced current was )99.6 ± 1.0 mV, which is close to the
nominal Ek ()104.3 mV). In order to quantify the inward rectiﬁcation,
we measured the slope conductance of the serotonin-suppressed current
at )105 and )65 mV (see Materials and methods). This slope was
signiﬁcantly (P < 0.05, n = 4) larger at )105 mV (on average
5.3 ± 0.2 pA ⁄mV) than at )65 mV (on average )0.4 ± 0.1 pA ⁄mV),
indicating the presence of strong inward rectiﬁcation.
The average current suppressed by serotonin for four FSIs is shown
in Fig. 5A. A curve of best ﬁt (see Materials and methods) for this
average current is also superimposed in Fig. 5A. The slope
conductance associated with the average serotonin-suppressed current
was estimated using this curve (see Materials and methods) and is
plotted in Fig. 5B. Such slope conductance is positive for voltages
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Fig. 3. Effects of serotonin on FSI excitability. (A) In a representative FSI, suprathreshold depolarizing current pulses were applied in control solution, in the
presence of serotonin (which had caused a 4 mV depolarization) and after serotonin washout. Five consecutive traces (interval 10 s) are superimposed for each
condition. Serotonin caused a large decrease in the latency of the ﬁrst spike and these effects were reversed on washout. Black traces were recorded in control
solution, before (left panel) and after (right panel) serotonin application; grey traces were recorded in the presence of serotonin and are truncated earlier to avoid
overlapping of the second spike with the ﬁrst spike of the traces recorded in control solution. (B) These traces, taken from the same experiment as in A, show that in
the presence of serotonin the ﬁrst inter-spike interval (ISI) was strongly reduced; it can also be appreciated that the temporal scattering of the second spike evoked by
a current step is greatly reduced in the presence of serotonin, resulting in a much lower variability of the ﬁrst ISI. (C) Average results for seven FSIs to which the
protocol illustrated in A and B was applied; the average ﬁrst ISI and the average latency of the ﬁrst spike for each FSI are represented by a point in a scatter plot in
control solution (open circle) and another point in serotonin (black circle). The points in the two conditions for each FSI are connected by a line. A strong decrease in
both parameters in the presence of serotonin is apparent for each cell. (D) The half-width of the action potentials evoked by current steps in control solution and in the
presence of serotonin did not differ signiﬁcantly. Average of the ﬁrst spikes elicited by 10 consecutive steps (delivered at 10 s intervals) for each condition. Dashed
lines indicate the threshold and peak of each action potential; double arrowed vertical bars represent the action potential amplitude; double arrowed horizontal bars
represent the action potential half-width.
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Fig. 4. Membrane conductances modulated by serotonin revealed by voltage-clamp experiments. (A) A representative example of the voltage-clamp experiments
carried out in the presence of TTX. Voltage steps (1 s) were applied to an FSI from the holding value ()80 mV) to levels between )100 and )40 mV (in 10 mV
increments), in control solution and in the presence of serotonin. (B) Steady-state currents (recorded at the end of each voltage step) plotted vs. voltage in control
solution (black) and in the presence of serotonin (grey) for the FSI of A. (C) Voltage dependence of the serotonin-suppressed currents in the same FSI. The steady-
state current induced by serotonin was calculated, for each voltage, by subtracting the membrane current measured in control solution from that measured in the
presence of serotonin. Serotonin-suppressed currents reversed around )100 mV and displayed prominent inward rectiﬁcation.
Fig. 5. Serotonin-suppressed current has small slope conductance at FSI resting potential. (A) Diamonds represent the average steady-state current suppressed by
serotonin at different voltages for four FSIs in which the protocol illustrated in Awas carried out (error bars represent SEs). Superimposed (in grey) is a curve of best
ﬁt for these points (see Materials and methods for details). The area shaded in grey is centred around the average resting membrane potential of FSIs and spans two
SDs ()69 ± 5 mV). (B) Estimated slope conductance associated with the serotonin-suppressed current, as a function of voltage. The curve of best ﬁt shown in Awas
used to obtain this slope conductance. As in A, the area shaded in grey is centred around the average resting membrane potential of FSIs and spans two SDs
()69 ± 5 mV). The two horizontal dashed lines enclose the levels (between )0.15 and 0.25 nS) attained by the average slope conductance within this voltage range,
where most resistance measurements were carried out.
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more negative than )68 mV but becomes negative for voltages more
positive than )68 mV. This function represents an estimate of the
contribution of the conductance suppressed by serotonin to the total
slope conductance of the cell. The addition of a current with negative
slope conductance produces a paradoxical decrease in the apparent
conductance measured with small current injections in the corre-
sponding voltage region (Westbrook & Mayer, 1984). The voltage
region including )69 ± 5 mV (corresponding to the average FSI
resting membrane potential ± SD) is highlighted in grey in both
graphs. This is the voltage range in which the input resistance was
measured both in control solution and in the presence of serotonin
(when FSIs were manually repolarized with current injections). In this
voltage region, the slope of the serotonin-suppressed current is
effectively close to zero; as a result, the slope conductance of the
serotonin-suppressed current is small, between )0.23 and 0.30 nS and
vanishing at )68 mV, close to the average FSI resting potential. This
observation therefore provided a biophysical explanation for the lack
of statistically signiﬁcant effects of serotonin on FSI input resistance
observed in most cases (see Discussion).
Inwardly rectifying currents mediated by Kir2 channels are
selectively blocked by low concentrations (100 lm) of extracellular
barium (Chatelain et al., 2005; Wilson, 2005). To test the involvement
of these currents in the effects of serotonin, we used bath applications
of barium chloride (100 lm) in ﬁve experiments in which a previous
application of serotonin had caused depolarizing effects
(8.6 ± 1.8 mV) in FSIs. Barium was applied after serotonin effects
had completely washed out. Barium per se induced membrane
depolarizations (12.0 ± 4.8 mV) in 5 ⁄ 5 FSIs. The input resistance was
not signiﬁcantly affected by barium in 5 ⁄ 5 cases (P > 0.05; at least
ﬁve pulses for each condition). In the continuous presence of barium,
the FSIs were manually repolarized at control level; under these
conditions, reapplication of serotonin failed to affect the FSI
membrane potential in all ﬁve cases. A representative example of
these experiments is illustrated in Fig. 6. It should be noted that, in the
absence of barium, reapplication of serotonin after complete washout
of the effects of a ﬁrst application elicited depolarizing effects similar
to those of the ﬁrst application (n = 4, not shown); thus, FSIs fully
retained their ability to respond to serotonin after a ﬁrst application.
Fig. 6. Barium (100 lm) occludes the excitatory effects of serotonin. (A) In this FSI, application of serotonin caused a reversible 10 mV depolarization, from a
resting membrane potential of )70 mV; this depolarization was accompanied by spontaneous action potentials. After washout of serotonin effects, application of
barium (100 lm) caused a depolarization ( 18 mV), also accompanied by spontaneous action potentials. In the continuous presence of barium, the FSI was
manually repolarized to )70 mV (as indicated by the bottom trace depicting the injected current); under these conditions, subsequent application of serotonin failed
to affect the FSI membrane potential. (B) Expanded traces (from the experiment in A) showing the spontaneous ﬁring activity observed in the presence of serotonin
(left) and barium (right).
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We concluded that the effects of serotonin were completely
occluded by the presence of extracellular barium; this observation
strongly supports the conclusion that serotonin effects were mediated
by a reduction in barium-sensitive inward rectifying potassium
currents.
Discussion
The main ﬁnding of this study is that serotonin directly depolarizes
striatal FSIs, strongly increasing their excitability. This effect is
mediated by activation of 5-HT2C receptors and involves the
suppression of an inwardly rectifying K+ current sensitive to low
barium concentrations.
Our pharmacological experiments clearly identiﬁed 5-HT2C recep-
tors as responsible for serotonin effects on FSIs. In fact, the
depolarizations induced by serotonin were completely reversed by
ketanserin, a 5-HT2 receptor antagonist, and by RS 102221, which
selectively blocks 5-HT2C receptors. After the addition of ketanserin
or RS 102221, the membrane potential often became more hyperpo-
larized than in control solution; this suggests that a tonic activation of
5-HT2C receptors by ambient serotonin was present in control
solution. In other brain regions, activation of 5-HT2 receptors causes
excitatory effects in various neuronal types, although inhibitory effects
have also been observed (Liu et al., 2003; Stanford et al., 2005).
Our voltage-clamp experiments allowed us to identify the biophys-
ical properties of a conductance modulated by serotonin in FSIs. These
data showed that serotonin suppressed a current that reversed very
close to potassium reversal potential and displayed prominent inward
rectiﬁcation. Inward rectiﬁcation is present in striatal FSIs (Kawag-
uchi, 1993) and Kir2 inwardly rectifying potassium currents are also
prominent in striatal projection neurons (Nisenbaum & Wilson, 1995;
Shen et al., 2008). The observation that serotonin effects were
completely occluded by barium, at a concentration that selectively
blocks the Kir2 channels (Choe et al., 1998; Wilson, 2005),
demonstrated that excitation of FSIs was mediated by suppression
of inwardly rectifying currents mediated by these channels. Interest-
ingly, an inwardly rectifying current mediated by Kir2 channels in
striatopallidal projection neurons is suppressed by acetylcholine
through muscarinic receptor activation (Shen et al., 2007). Thus,
Kir2 channels are a major target for neuromodulation in the striatum.
The properties of the current suppressed by serotonin provide a
simple explanation for the lack of effect of serotonin on FSI input
resistance, despite the presence of robust depolarizations. Input
resistance measurements were carried out at control resting membrane
potential in both the absence and presence of serotonin (when FSIs
were repolarized manually). In this voltage region ()73 to )61 mV),
the slope conductance of the current suppressed by serotonin was
extremely small in absolute value, i.e. < 0.3 nS. Classic studies on
N-methyl-d-aspartate receptors have shown that the activation of a
voltage-dependent current with negligible slope conductance in a
certain voltage range results in no changes in the apparent cell input
resistance measured in that region, whereas a paradoxical increase in
input resistance is observed in a voltage region where the current has
negative slope (Westbrook & Mayer, 1984; Mayer & Westbrook,
1985). In the present case, serotonin suppressed a voltage-dependent
current; the magnitude of its slope conductance should be compared
with the average FSI membrane conductance in control solution,
which was C = 5.7 nS. The fractional contribution of the serotonin-
suppressed conductance to the total conductance is
DC ⁄C £ (0.3 nS ⁄ 5.7 nS) = 5.3%; the reciprocal relationship between
resistance and conductance (R = 1 ⁄C) implies that DR ⁄ R = DC ⁄C.
Therefore, 5.3% is also an upper limit for the percent change in
resistance caused by the serotonin-suppressed current. Whole-cell
recordings are inevitably contaminated by thermal and synaptic noise,
as well as by small variations in the electrode access resistance; it is
therefore not surprising that such small changes in input resistance did
not give rise to statistically signiﬁcant effects. Consistently, 100 lm
barium also did not induce signiﬁcant changes in FSI input resistance,
despite its action as an inward rectiﬁer potassium current blocker. It
should be noted, however, that suppression of an inwardly rectifying
potassium current will still produce robust depolarizations and
increases in excitability. These phenomena were indeed observed in
our experiments. In a minority of serotonin-responsive FSIs, serotonin
induced spontaneous ﬁring, which was never present in these neurons
in control solution; in the remaining ones, in the presence of serotonin,
the ability of a depolarizing input to generate action potentials was
strongly increased, even when the cells were repolarized to control
levels. Furthermore, when stimuli that were suprathreshold in control
solution were used, in the presence of serotonin, the latency of the ﬁrst
spike strongly decreased and the initial ﬁring frequency strongly
increased. This suggests that FSIs will be much more responsive to
cortical glutamatergic inputs (Ramanathan et al., 2002) in the presence
of serotonin in the intact brain, resulting in stronger feed-forward
inhibition of projection neurons. In-vivo studies have shown that FSIs
respond earlier than projection neurons to cortical inputs (Mallet et al.,
2005). By exciting FSIs, serotonin may exacerbate this difference in
latency, thus increasing the ability of FSI to limit the temporal extent
of projection neuron responses and possibly suppressing responses
altogether in those projection neurons that receive weaker cortical
stimuli.
Approximately 22% of FSIs did not respond to the standard
serotonin concentration used in this study (30 lm); the electrophys-
iological properties of these FSIs did not differ signiﬁcantly from
those of serotonin-responsive FSIs. In these cells, increasing the
serotonin concentration up to 120 lm was also ineffective, suggesting
that they belonged to a subpopulation that was unresponsive to
serotonin. Previous histological studies have shown that the 5-HT2C
are not uniformly distributed in the striatum, being more densely
expressed in the matrix or striosome compartments, respectively
(Ward & Dorsa, 1996). Furthermore, the distribution of Kir2 channels
is also uneven in the striatal compartments (Pruss et al., 2003). It is
possible that the expression of the 5-HT2C receptors (or that of the
potassium channels targeted by it) was low or absent in the FSIs that
did not respond to serotonin, as a result of their compartmental
location. Further studies will be required to clarify whether the FSIs
that do not respond to serotonin belong to a speciﬁc striatal
compartment.
The present observations on FSI extend our previous ﬁnding that
serotonin excites striatal cholinergic interneurons (Blomeley & Bracci,
2005). It is worth noting that, although serotonin affects different
membrane mechanisms in cholinergic interneurons and FSIs, in both
cases the effects are mediated by 5-HT2 receptors. Cholinergic
interneurons and FSIs control projection neurons in different ways but
their actions on these cells may converge at a functional level. We
have shown using paired recordings that cholinergic interneurons
inhibit cortical glutamatergic input to projection neurons through a
presynaptic mechanism (Pakhotin & Bracci, 2007). Projection neurons
are also strongly affected by postsynaptic GABAA receptors (Ade
et al., 2008) and are powerfully controlled by FSIs through activation
of these receptors (Koos & Tepper, 1999; Tepper et al., 2007). The
present data, when paired with our previous observations on
cholinergic interneurons, suggest that the presence of serotonin in
the striatum will decrease the activity of striatal projection neurons
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through a combination of increased presynaptic inhibition of their
glutamatergic input (caused by the excitation of cholinergic interneu-
rons) and increased GABAergic postsynaptic inhibition (caused by the
excitation of FSIs).
From a clinical perspective, it is interesting that selective serotonin
reuptake inhibitors, which are widely used for the treatment of
depression, can produce extrapyramidal motor effects, including
akathisia and dystonia (Gerber & Lynd, 1998). The present results
suggest that increased activity of striatal FSIs, due to prolonged
activation of 5-HT2 receptors in patients exposed to selective serotonin
reuptake inhibitors, may cause excessive suppression of the GABA-
ergic striatal output and this could be an important causal factor in the
genesis of motor side effects (Gubellini et al., 2006).
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